Description
BSE informs trading members that equity shares of Gaudium IVF and Women Health Limited (Scrip Code: 544709, Symbol: GAUDIUMIVF) will be listed on the Exchange in due course, with the exact listing date to be announced separately.
Summary
BSE has notified trading members that equity shares of Gaudium IVF and Women Health Limited will be listed and admitted to dealings on the Exchange in due course. The company has been assigned Scrip Code 544709 and symbol GAUDIUMIVF. The exact listing date and further security details will be communicated via a separate notice.
Key Points
- Equity shares of Gaudium IVF and Women Health Limited will be listed on BSE.
- Scrip Code: 544709 | Symbol: GAUDIUMIVF | ISIN: INE0P8B01020
- Actual listing date has not yet been announced and will be communicated through a separate notice.
- Notice issued by Hardik Bhuta, Assistant Vice President, BSE Limited.
Regulatory Changes
No regulatory changes introduced. This is a standard listing announcement under BSE’s company-related notifications for equity segment admissions.
Compliance Requirements
- Trading members should note the scrip details (Code: 544709, Symbol: GAUDIUMIVF, ISIN: INE0P8B01020) in anticipation of the listing.
- Members should await the subsequent notice from BSE for the confirmed listing date and full security details before initiating trades.
Important Dates
- Notice Date: February 26, 2026
- Listing Date: To be announced via a separate notice.
Impact Assessment
This announcement marks the imminent market debut of Gaudium IVF and Women Health Limited on BSE’s equity segment. Trading members and investors in the healthcare/fertility services sector should monitor for the follow-up listing date notice. The listing will create a new tradeable instrument (GAUDIUMIVF) on the exchange, expanding options for investors in the women’s health and IVF industry.
Impact Justification
New equity listing announcement for a healthcare company; impacts trading members and investors interested in this scrip, but listing date is still pending a separate notice.